AGMB Latest Press Releases

-- September 14, 2026 --

Agomab Announces Positive Phase 1 Results for AGMB-447 in Patients with Idiopathic Pulmonary Fibrosis and Design of Phase 2 INSPIRIA Study Globe Newswire 4:05 PM

-- September 11, 2026 --

Agomab Announces Appointments of Marino Garcia and Dr. Naimish Patel to Board of Directors Globe Newswire 4:05 PM

-- September 3, 2026 --

Agomab to Participate in Upcoming Investor Conferences Globe Newswire 4:05 PM

-- August 10, 2026 --

Agomab Announces Proposed Appointments of Marino Garcia and Dr. Naimish Patel to Board of Directors Globe Newswire 4:07 PM

-- August 6, 2026 --

Agomab Reports Half Year 2026 Financial Results and Confirms 2026 Outlook Globe Newswire 4:01 PM

-- June 23, 2026 --

Agomab Announces Design of NOV-ERA Phase 2b Study with Ontunisertib in Fibrostenosing Crohn's Disease Globe Newswire 4:05 PM

-- May 27, 2026 --

Agomab Announces Results of Annual General Meeting Globe Newswire 5:00 AM

-- May 14, 2026 --

Agomab to Participate in Upcoming Conferences Globe Newswire 7:30 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software